Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
12.8M |
$53.9M |
$4.22 |
Jul 16, 2021 |
By General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Common Stock |
4.78M |
$13.9M |
$2.90 |
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
279K |
$1.18M |
$4.22 |
Jul 16, 2021 |
By General Catalyst Group V, Supplemental, L.P. |
Evolv Technologies Holdings, Inc. |
10%+ Owner |
Class A Common Stock |
272K |
$1.15M |
$4.22 |
Jul 16, 2021 |
By GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Common Stock |
99.9K |
$290K |
$2.90 |
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series C-1 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series C-1 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series C-2 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series C-2 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series D Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series D Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series E Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by GC Entrepreneurs Fund V, L.P. |
Fractyl Health, Inc. |
10%+ Owner |
Series E Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Directly held by General Catalyst Group V, L.P. |